Squamous cell carcinoma of the skin screening

Revision as of 20:07, 25 August 2015 by Turky Alkathery (talk | contribs) (Turky Alkathery moved page Squamous cell carcinoma screening to Squamous cell carcinoma of the skin screening without leaving a redirect)
Jump to navigation Jump to search

Squamous cell carcinoma of the skin Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Squamous cell carcinoma of the skin from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT Scan

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Squamous cell carcinoma of the skin screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Squamous cell carcinoma of the skin screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Squamous cell carcinoma of the skin screening

CDC on Squamous cell carcinoma of the skin screening

Squamous cell carcinoma of the skin screening in the news

Blogs on Squamous cell carcinoma of the skin screening

Directions to Hospitals Treating Squamous cell carcinoma of the skin

Risk calculators and risk factors for Squamous cell carcinoma of the skin screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2], Raviteja Guddeti, M.B.B.S. [3]

Screening

Since Squamous cell carcinoma is almost always cured without specified screening no studies have shown that such screening will improve the already high cure rates for this type of skin carcinoma. For carcinoma of prostrate, prostrate specific antigen (PSA) is often used for diagnosis. Squamous cell carcinoma of prostrate is very aggressive in nature. It is difficult to detect as there is no increase in prostate specific antigen levels seen; meaning that the cancer is often diagnosed at an advanced stage.

References

Template:WikiDoc Sources